Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of CAD 9.91 million. The enterprise value is 6.97 million.
| Market Cap | 9.91M |
| Enterprise Value | 6.97M |
Important Dates
The last earnings date was Monday, April 27, 2026.
| Earnings Date | Apr 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medicure has 10.44 million shares outstanding.
| Current Share Class | 10.44M |
| Shares Outstanding | 10.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 26.27% |
| Owned by Institutions (%) | 0.62% |
| Float | 5.28M |
Valuation Ratios
The trailing PE ratio is 1.40.
| PE Ratio | 1.40 |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 11.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.98 |
| EV / Sales | 0.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.02 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.13% and return on invested capital (ROIC) is -57.03%.
| Return on Equity (ROE) | -42.13% |
| Return on Assets (ROA) | -15.76% |
| Return on Invested Capital (ROIC) | -57.03% |
| Return on Capital Employed (ROCE) | -51.65% |
| Weighted Average Cost of Capital (WACC) | 8.97% |
| Revenue Per Employee | 759,342 |
| Profits Per Employee | -186,763 |
| Employee Count | 38 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 5.50 |
Taxes
In the past 12 months, Medicure has paid 208,000 in taxes.
| Income Tax | 208,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.46% in the last 52 weeks. The beta is 1.00, so Medicure's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +14.46% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 42.49 |
| Average Volume (20 Days) | 2,622 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of CAD 28.86 million and -7.10 million in losses.
| Revenue | 28.86M |
| Gross Profit | 11.75M |
| Operating Income | -6.89M |
| Pretax Income | -6.89M |
| Net Income | -7.10M |
| EBITDA | -4.24M |
| EBIT | -6.89M |
| Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 3.84 million in cash and 891,000 in debt, giving a net cash position of 2.94 million or 0.28 per share.
| Cash & Cash Equivalents | 3.84M |
| Total Debt | 891,000 |
| Net Cash | 2.94M |
| Net Cash Per Share | 0.28 |
| Equity (Book Value) | 12.91M |
| Book Value Per Share | n/a |
| Working Capital | 274,000 |
Cash Flow
| Operating Cash Flow | -560,000 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.65M |
| Net Borrowing | -415,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 40.71%, with operating and profit margins of -23.87% and -24.60%.
| Gross Margin | 40.71% |
| Operating Margin | -23.87% |
| Pretax Margin | -23.87% |
| Profit Margin | -24.60% |
| EBITDA Margin | -14.70% |
| EBIT Margin | -23.87% |
| FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -71.58% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
| Last Split Date | Nov 2, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0666666 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |